Göm menyn

Publications for Måns Edström

Co-author map based on Web of Sciences articles 2007-

Publications mentioned in social media 11 times*

Journal Articles

Mika Gustafsson, Måns Edström, Danuta Gawel, Colm Nestor, Hui Wang, Huan Zhang, Fredrik Barrenäs, James Tojo, Ingrid Kockum, Tomas Olsson, Jordi Serra-Musach, Nuria Bonifaci, Miguel Angel Pujana, Jan Ernerudh and Mikael Benson
  Integrated genomic and prospective clinical studies show the importance of modular pleiotropy for disease susceptibility, diagnosis and treatment
  Genome Medicine, 2014, 6(17), .
   Fulltext  PDF  
 Web of Science® Times Cited: 9

Johan Mellergård, Måns Edström, Maria Jenmalm, Charlotte Dahle, Magnus Vrethem and Jan Ernerudh
  An Increase in B cell and Cytotoxic NK cell Proportions and Increased T cell Responsiveness in Blood of Natalizumab-treated Multiple Sclerosis Patients
  PLoS ONE, 2013, 8(12), .
   Fulltext  PDF  
 Web of Science® Times Cited: 18

Måns Edström, Johan Mellergård, Jenny Mjösberg, Maria Jenmalm, Magnus Vrethem, R Press, Charlotte Dahle and Jan Ernerudh
  Transcriptional characteristics of CD4+ T cells in multiple sclerosis: relative lack of suppressive populations in blood
  Multiple Sclerosis, 2011, 17(1), 57-66.
 Web of Science® Times Cited: 14

Johan Mellergård, Måns Edström, Magnus Vrethem, Jan Ernerudh and Charlotte Dahle
  Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid
  Multiple Sclerosis, 2010, 16(2), 208-217.
   Fulltext  PDF  
 Web of Science® Times Cited: 76

Conference Articles

Måns Edström, Charlotte Dahle, Maria Jenmalm, Johan Mellergård, Jenny Mjösberg, Rayomand Press, Magnus Vrethem and Jan Ernerudh
  Th1/Th2/Th17 and Treg related transcription factors and cytokines in multiple sclerosis

Ph.D. Theses

Måns Edström
  Regulation of immunity in Multiple Sclerosis: CD4+ T cells and the influence of natalizumab

  Fulltext PDF

* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.


Responsible for this page: Peter Berkesand
Last updated: 2017-02-21